Open access
Jul 2026
Macrophage heterogeneity in breast cancer microenvironment and development of a prognostic model: exploring TFF1 as a novel therapeutic target.
The comprehensive evaluation determined that high-risk cohort's immune microenvironment exhibited a greater inclination toward immune suppression, whereas the low-risk cohort was markedly predisposed to anti-tumor immune responses, underscores cellular heterogeneity inherent in BRCA TME.
Lin Chen, Zhiqiang Chen, Bailu Shi et al.
· Cancer Immunology and Immuno... · 0 citations